During the past decade, Kardiologie Darmstadt conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kardiologie Darmstadt" #1 collaborator was "Daiichi Sankyo Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kardiologie Darmstadt" are "Arrythmia" (1 trials), "Arrythmia, Implatable Cardioverter Defibrillation, Lead" (1 trials), "Hypercholesterolemia" (1 trials), "Implantable Cardioverter Defibrillator" (1 trials) and "Mixed Dyslipidemia" (1 trials). Many other conditions were trialed in "Kardiologie Darmstadt" in a lesser frequency.

Most popular intervention types in "Kardiologie Darmstadt" are "Device" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bempedoic Acid 180Mg/Ezetimibe 10Mg Tab" (1 trials), "ICD" (1 trials), "NAVIGO 4LV lead implant" (1 trials) and "No study drug" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kardiologie Darmstadt" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kardiologie Darmstadt". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kardiologie Darmstadt, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kardiologie Darmstadt, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".